Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

72 trials with published results (18%)

Research Maturity

295 completed trials (73% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.7%

15 terminated out of 406 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

28%

112 trials in Phase 3/4

Results Transparency

24%

72 of 295 completed with results

Key Signals

72 with results95% success15 terminated

Data Visualizations

Phase Distribution

352Total
Not Applicable (135)
Early P 1 (1)
P 1 (55)
P 2 (49)
P 3 (72)
P 4 (40)

Trial Status

Completed295
Unknown49
Recruiting22
Terminated15
Not Yet Recruiting9
Withdrawn8

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 295 completed trials

Clinical Trials (406)

Showing 20 of 20 trials
NCT07216482Phase 3RecruitingPrimary

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

NCT07100418Phase 2Active Not RecruitingPrimary

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

NCT00001154Completed

Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

NCT07578090Recruiting

Regional Innovation in Chronic Disease and Elderly Care

NCT07230730Phase 3RecruitingPrimary

A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

NCT07588256Not ApplicableRecruiting

New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases

NCT06603363Not ApplicableRecruiting

Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

NCT02262832Phase 3Active Not Recruiting

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

NCT02262806Phase 2Active Not Recruiting

Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy

NCT06951451Not ApplicableEnrolling By Invitation

Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman

NCT07546162Not Yet RecruitingPrimary

Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening

NCT07494526Not Yet Recruiting

Chronic Kidney Disease and Metabolic Disorders in the Elderly

NCT06831162Not ApplicableEnrolling By Invitation

Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

NCT07117695Not ApplicableNot Yet Recruiting

Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors

NCT07400549Not ApplicableRecruiting

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

NCT01275300Not ApplicableCompletedPrimary

Biosynthesis of PGD2 in Vivo

NCT06471218Phase 2CompletedPrimary

Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

NCT07229118Phase 1RecruitingPrimary

A Study to Evaluate COR-1004 in Adult Volunteers.

NCT07334834Not ApplicableRecruitingPrimary

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

NCT07097831Phase 1CompletedPrimary

A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

Scroll to load more

Research Network

Activity Timeline